A Type IV Secretion System Contributes to Intracellular Survival and Replication of Burkholderia cenocepacia by S. Umadevi Sajjan et al.
INFECTION AND IMMUNITY, Dec. 2008, p. 5447–5455 Vol. 76, No. 12
0019-9567/08/$08.000 doi:10.1128/IAI.00451-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
A Type IV Secretion System Contributes to Intracellular Survival and
Replication of Burkholderia cenocepacia
S. Umadevi Sajjan,1 Lisa A. Carmody,1 Carlos F. Gonzalez,2 and John J. LiPuma1*
Department of Pediatrics and Communicable Disease, University of Michigan Medical School, Ann Arbor, Michigan 48109,1 and
Department of Plant Pathology and Microbiology, Texas A&M University, College Station, Texas 778432
Received 11 April 2008/Returned for modification 13 May 2008/Accepted 16 September 2008
Burkholderia cenocepacia is an important respiratory pathogen in persons with cystic fibrosis (CF). Recent studies
indicate that B. cenocepacia survives within macrophages and airway epithelial cells in vitro by evading endosome-
lysosome fusion. We investigated the role of a plasmid-encoded type IV secretion system in the intracellular survival,
replication, and processing ofB. cenocepacia. Both a wild-type strain (K56-2) and its type IV secretion systemmutant
(designated LC101) entered and replicated in CF airway epithelial cells and monocyte-derived macrophages.
However, significantly more intracellular K56-2 than LC101 bacteria were found in both cell types at 24 h
postinfection. Colocalization of bacteria with markers of the classical endocytic pathway indicated that although
both K56-2 and LC101 reside transiently in early endosomes, a greater proportion of the mutant bacteria are
targeted to lysosomal degradation. In contrast, wild-type bacteria escape from the classical endocytic pathway and
traffic to the endoplasmic reticulum, where they replicate. Our results show that the intracellular processing of B.
cenocepacia is similar in both professional and nonprofessional phagocytes and that a functional plasmid-encoded
type IV secretion system contributes to the survival and replication of B. cenocepacia in eukaryotic cells.
Burkholderia cenocepacia, a member of the Burkholderia ce-
pacia complex, causes respiratory tract infection in persons
with cystic fibrosis (CF). B. cenocepacia is a facultative intra-
cellular bacterium that has been observed within airway epi-
thelial cells and alveolar macrophages in vivo (5, 27). Previous
work has demonstrated that the species enters and replicates
within airway epithelial cells and monocyte-derived macro-
phages cultured in vitro (3, 20, 30, 32, 34). We recently dem-
onstrated that B. cenocepacia interferes with the normal endo-
cytic pathway, prevents acidification of bacterium-containing
vacuoles, and traffics to and replicates in the endoplasmic re-
ticulum (ER) of CF airway epithelial cells in vitro (30). Others
have shown that B. cenocepacia persists with little replication
within endosomes in murine macrophages and amoebae by
delaying phagosome maturation and acidification (16, 17). The
bacterial factors involved in these events have yet to be iden-
tified.
Several pathogenic bacterial species survive and replicate
within host cells by modulating the processing of bacterium-
containing vacuoles to evade their fusion with lysosomes (21,
23). This vacuole hijacking may involve bacterial effectors that
interfere with host factors that are important in vacuole traf-
ficking and membrane fusion. For example, the Spi/Ssa type III
secretion system of Salmonella enterica exports SpiC into the
host cell cytosol, where it affects host vacuolar trafficking ma-
chinery (35). The Inc proteins from Chlamydia trachomatis
interfere with the processing of nascent chlamydial vacuoles
(33). Effector proteins exported by the Dot/Icm type IV secre-
tion system (T4SS) of Legionella pneumophila and the VirB
T4SS of Brucella species are required to modulate the matu-
ration of bacterium-containing phagosomes (8, 14, 25, 38). In
Bartonella henselae, effector proteins exported by the VirB/
VirD4 T4SS similarly play roles in host cell invasion and intra-
cellular replication (31).
As an opportunistic human pathogen, clear distinctions be-
tween virulent and avirulent B. cenocepacia strains are difficult;
however, clinical-outcome data suggest the epidemic ET12
clonal lineage is, in general, more virulent than other B. ceno-
cepacia strains (13, 18). Recently, two T4SSs belonging to the
ET12 lineage (which includes strain K56-2) have been identi-
fied in B. cenocepacia by genomewide analysis (9). One of
these is encoded on chromosome 2 and bears homology to the
VirB/D4 T4SS of Agrobacterium tumefaciens (6). The other,
termed the Ptw T4SS, is a chimeric system composed of
VirB/D4 and F-specific subunits encoded on a resident 92-kb
megaplasmid (6, 9). Insertional inactivation of ptwD4, which
has homology to coupling proteins involved in effector trans-
location in other T4SSs, of the plasmid-encoded Ptw system
abolished the plant water-soaking phenotype of B. cenocepacia
strain K56-2 (9). In the study reported here, we investigated
whether the B. cenocepacia Ptw T4SS is involved in intracellu-
lar bacterial replication and/or bacterium-containing vacuole
processing. We constructed a ptwD4 mutant and compared its
capacity to invade and replicate in airway epithelial cells and
macrophages to that of the wild-type parent.
MATERIALS AND METHODS
Bacterial strains and growth conditions. B. cenocepacia K56-2 was isolated
from a CF patient and is a representative of the epidemic ET12 lineage. For
bacterial-invasion assays, strains were grown on Luria-Bertani (LB) agar (Fisher
Scientific, Hampton, NH), with or without 300 g ml1 of tetracycline, for 24 h.
A single colony was inoculated into 5 ml of LHC-8 medium (Invitrogen, Carls-
bad, CA) for use with IB3 cells or RPMI 1640 medium (Invitrogen) for use with
U937-derived macrophages and grown overnight at 37°C on an orbital shaker at
230 rpm. Bacteria were harvested by centrifugation, washed once with phos-
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phate-buffered saline (PBS), and suspended to the desired concentration in
LHC-8 or RPMI 1640.
Construction of the ptwD4 mutant. A 2.0-kb genomic fragment containing the
ptwD4 gene was amplified from B. cenocepacia K56-2 with primers PD4-1 (5-T
GACTCAGCGAAGGAA-3) and PD4-2 (5-ATCCGGTGGAAGCAA-3) as
previously described (9) and cloned into pCR2.1 (Invitrogen). To inactivate
ptwD4, a 1,299-bp tetracycline resistance (Tcr) cassette was amplified from
pBR325 (2) using primers containing AatII sites and cloned into the AatII site of
ptwD4. The disrupted ptwD4 gene was excised from pCR2.1 by double digestion
with SacI and XbaI and cloned into SacI/XbaI-linearized pEX18Tc, which is a
suicide vector in B. cenocepacia (12). The suicide construct was introduced into
K56-2 by triparental mating using pRK2013 as a helper (11). Mutants produced
by allelic exchange were selected on LB agar containing 300 g ml1 tetracy-
cline. Tcr clones were cultured on medium containing 5% sucrose to select for
double-crossover events. Mutagenesis of ptwD4 was confirmed by PCR and
Southern blot analyses. The K56-2 isogenic mutant containing the insertionally
inactivated ptwD4 gene was designated strain LC101.
RT-PCR. Reverse transcription (RT)-PCR was performed to evaluate the
expression of genes downstream of ptwD4. Total RNA was isolated from mid-
log-phase cultures of K56-2 or LC101 using the PureLink RNA Mini Kit (In-
vitrogen) and then treated with DNase I (Invitrogen) for 15 min. RT-PCR was
performed using the SuperScript III One-Step RT-PCR System (Invitrogen) to
target four open reading frames (ORFs) immediately downstream of ptwD4. The
following primers were used: PC1 (5-TCTGCAGCAGTTCTCGTACACGTT-3)
and PC2 (5-TTGACGGAGTGGTGGCTAATCACA-3), ORF1-1 (5-AGTTCT
CGGCGATCAATGAGCGAT-3) and ORF1-2 (5-GTGCAAACTCACGCGAC
ACAAGAT-3), ORF2-1 (5-TTCCATGCATTCCTACTCGACGGT-3) and
ORF2-2 (5-GTTTGAATCTCGTCCGCCTTGACA-3), and ORF3-1 (5-A
TCAGTCGATGAAGCGCGTGAGAT-3) and ORF3-2 (5-ACATTGACC
GGTAGTTCCGATGGAC-3). Negative control reactions were performed
by substituting Taq DNA polymerase for SuperScript III RT/Taq mix.
Complementation of the ptwD4mutant. A 3.1-kb genomic fragment containing
the ptwD4 gene was amplified from B. cenocepacia K56-2 with primers PD4-2B
(5-CGCAGACTGCGCGAATGC-3) and PD4-3 (5-CCGTACCTTACCGGG
TGAAGG-3) and cloned into pCR2.1. The ptwD4 gene with a 1.1-kb flanking
upstream region was excised from pCR2.1 by double digestion with XbaI and
HindIII and cloned into XbaI/HindIII-linearized pBcRLaR-CL, which is derived
from pBBR1 by the addition of the chloramphenicol cassette from EZ::Tn
(EpiCentre) and the multiple cloning site from pCR2.1 (Invitrogen). The com-
plement construct was introduced into LC101 by triparental mating as described
above. Mutants containing the complementing plasmid were selected for on LB
agar containing 300 g ml1 tetracycline and 200 g ml1 chloramphenicol and
confirmed by miniprep isolation of plasmid DNA and PCR. Stability of the
complement, designated strain LC102, was confirmed by serial passage on non-
selective medium. LC102 was found to be stable at least through five serial
passages on nonselective medium.
Growth curves. Overnight cultures of bacterial isolates were adjusted to an
optical density at 600 nm of 0.05 in cell culture medium (RPMI 1640 or LHC-8)
without serum or antibiotics. The optical density at 600 nm was measured every
hour for 24 h.
Cell culture. IB3 cells are an adeno-associated virus-transformed human bron-
chial epithelial cell line derived from a CF patient (kindly provided by P. Zeitlin,
Johns Hopkins University). IB3 cells were grown in LHC-8 cell culture medium
with glutamine supplemented with 5% fetal bovine serum, 50 U ml1 penicillin,
and 50 g ml1 streptomycin. The human monocytic cell line U937 was obtained
from the American Type Culture Collection (Manassas, VA). U937 cells were
maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum,
50 U ml1 penicillin, and 50 g ml1 streptomycin. Prior to use in infection
experiments, U937 cells were stimulated with phorbol 12-myristate-13-acetate
(PMA) (Sigma, St. Louis, MO) for 72 h in collagen-coated plates to promote
their differentiation into macrophages. For bacterial-invasion and -replication
experiments, IB3 or U937 cells (5  104 cells/well) were seeded in 24-well tissue
culture plates (BD Falcon, Franklin Lakes, NJ). For immunofluorescence exper-
iments, cells (105 cells/well) were cultured in collagen-coated four-well chamber
slides (BD BioCoat, Bedford, MA). The cultures were grown at 37°C with 5%
CO2. Prior to infection, cells were incubated overnight in antibiotic- and serum-
free medium.
Binding assays. Binding of bacteria to cells was determined as previously
described (29). IB3 cells grown in six-well plates were lightly fixed with 0.5%
paraformaldehyde for 30 min and washed with Dulbecco’s PBS (D-PBS) con-
taining 0.5% bovine serum albumin (BSA). Fluorescein isothiocyanate (FITC)-
labeled K56-2 or LC101 (25) bacteria at a multiplicity of infection (MOI) of 100
were centrifuged (250  g for 15 min) onto the monolayers, which were then
incubated at 37°C for 2 h. The cells and adherent bacteria were detached from
the plate by using Cell Dissociation Buffer (Invitrogen), washed with PBS-BSA,
fixed in 1% paraformaldehyde, and analyzed with a Becton Dickinson FACS-
Calibur using CellQuest software.
Bacterial-invasion and intracellular-replication assays. Invasion and intracel-
lular replication by B. cenocepacia were determined as previously described (30).
Briefly, IB3 cells or macrophages were infected with K56-2 or LC101 at an MOI
of 1 or 10 for 2 h. Extracellular bacteria were then killed by incubating the cells
for 2 h in medium containing 500 g ml1 ceftazidime (Sigma) and 250 g ml1
gentamicin (Sigma). The cells were washed with D-PBS, and an aliquot of the
final wash was plated to determine the number of viable extracellular bacteria
remaining. In order to determine the efficacy of killing bacteria that might be
adherent to cells or to the culture well, IB3 cells or macrophages grown in 24-well
plates were fixed as in the binding assays. Cells were incubated with K56-2 or
LC101 at an MOI of 10 for 2 h and then washed and treated with ceftazidime and
gentamicin as in the invasion assays. Following antibiotic treatment, the cells
were washed, collected in 0.1% Triton X-100, serially diluted, and plated to
determine the number of viable bacteria. Greater than 99.9% of K56-2 and
LC101 bacteria were killed by the antibiotic treatment. For invasion assays, cells
were lysed in 0.1% Triton X-100, serially diluted, and plated to determine the
number of intracellular bacteria. For intracellular-replication assays, cells were
incubated for a further 20 h in medium containing 100 g ml1 gentamicin
before being lysed for determination of the number of intracellular bacteria.
Cytotoxicity assay. The viability of cells after bacterial infection was measured
using the Live/Dead Viability/Cytotoxicity Kit (Invitrogen) following the manu-
facturer’s instructions. In brief, 8  103 IB3 cells or macrophages were seeded in
96-well tissue culture plates and infected with K56-2 or LC101 at an MOI of 1 for
2 h. Extracellular bacteria were killed as described above for bacterial-replication
assays, and the cells were incubated for a further 20 h in medium containing 100
g ml1 gentamicin. The cells were washed three times in 300 l D-PBS and
then incubated with 1 M ethidium homodimer 1 and 1 M calcein AM for
macrophages or 5 M ethidium homodimer 1 and 2.5 M calcein AM for IB3
cells. After 40 min, fluorescence was measured using a SpectraMax GeminiEM
plate reader (Molecular Devices, Sunnyvale, CA).
Primary and secondary antibodies. Monoclonal antibody to LAMP1 was pur-
chased from the Hybridoma Facility, University of Iowa, Iowa City. Monoclonal
antibody to cathepsin D and polyclonal antibodies to EEA1, Rab7, and calnexin
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal
rabbit antibody (R418) to whole lysed B. cenocepacia has been described previ-
ously (27). Secondary antibodies conjugated with Alexa Fluor 488 or Alexa Fluor
594 were purchased from Molecular Probes (Carlsbad, CA).
Immunofluorescence staining and microscopy. Immunofluorescence experi-
ments were performed as previously described (30). IB3 cells or macrophages
were infected with K56-2 or LC101 at an MOI of 20 and incubated for 30 min,
2 h, 4 h, or 24 h. The cells were washed three times in D-PBS to remove unbound
bacteria and then fixed and permeabilized in cold methanol for 5 min at 20°C.
The slides were blocked with 5% BSA in D-PBS for 1 h and then incubated with
the appropriate primary antibody overnight at 4°C. Bound antibodies were de-
tected by anti-mouse (LAMP1 and cathepsin D) or anti-goat (EEA1, Rab7, and
calnexin) and anti-rabbit (R418) antibodies conjugated to Alexa Fluor 488 or
Alexa Fluor 594. The cells were counterstained with DAPI (4,6-diamidino-2-
phenylindole) for 5 min, mounted, and visualized using a Zeiss LSM 510 confocal
laser microscope. The proportion of intracellular bacteria colocalizing with each
marker of interest was determined by counting all intracellular bacteria in 10 to
12 microscopic fields.
Labeling cells with LysoTracker Red. Wild-type K56-2 and LC101 were la-
beled with FITC as previously described (28). IB3 cells were infected with
bacteria at an MOI of 20 and incubated for 1 h or 5 h. The cells were washed to
remove unbound bacteria and incubated with 100 nM LysoTracker Red (Invitro-
gen) for 1 h. Macrophages were infected with bacteria at a MOI of 20, incubated
for 5 h, washed, and incubated with 100 nM LysoTracker Red. For 30-min
infections, macrophages were preloaded with 100 nM LysoTracker Red for 30
min and then infected with bacteria at an MOI of 20 in medium containing 100
nM LysoTracker Red and incubated for another 30 min. The cells were washed
to remove unbound bacteria, fixed with 3.7% formaldehyde (vol/vol) for 30 min,
mounted, and visualized by fluorescence microscopy.
Statistical analysis. Statistical analyses were carried out using Sigma Stat
(SPSS Inc., Chicago, IL). Data were expressed as geometric means and standard
errors of the mean (SEM). Student’s t test was used to compare two groups, and
parametric one-way analysis of variance with the Tukey posttest was used to
compare three or more groups. Differences were considered statistically signif-
icant if the P value was 0.05.
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RESULTS
Mutagenesis of the B. cenocepacia Ptw T4SS. We inactivated
the ptwD4 gene of the plasmid-encoded Ptw T4SS of B. ceno-
cepacia K56-2 to determine the potential role of the system in
intracellular bacterial trafficking and replication. ptwD4 en-
codes a protein with Walker A and B nucleotide binding/
hydrolysis motifs (9). Its strong homology to the coupling pro-
teins of other T4SSs (e.g., VirD4) suggests a role in effector
protein translocation (1). PCR and Southern blot analyses of
wild-type K56-2 and the novel ptwD4 mutant (designated
LC101) confirmed the insertion of a tetracycline resistance
cassette in ptwD4. Mutation of ptwD4 resulted in loss of the
plant water-soaking phenotype as previously observed (9) but
did not result in any observable growth defects of planktonic
cultures of K56-2 or LC101 grown in cell culture medium
(RPMI 1640 or LHC-8) without serum or antibiotics to repro-
duce the conditions used during infection of cell cultures (data
not shown). Wild-type K56-2 and LC101 were used in parallel
in all binding, invasion, replication, and colocalization experi-
ments.
Invasion and intracellular replication of K56-2 and LC101.
We examined whether mutation of ptwD4 attenuates the ca-
pacity of B. cenocepacia to invade, survive, or replicate within
CF airway epithelial (IB3) cells. As we observed previously,
wild-type K56-2 invaded and replicated within IB3 cells (30).
In invasion assays, IB3 cells were infected with bacteria at an
MOI of 10 and incubated for 2 h. After removal of unbound
bacteria, the cells were incubated with gentamicin and ceftaz-
idime for a further 2 h to kill extracellular bacteria. The cells
were then washed, lysed, and plated to determine the number
of intracellular bacteria. Plating from the final wash fluid re-
vealed negligible numbers of viable bacteria for both K56-2
and LC101 (data not shown). Cells infected with wild-type
K56-2 had a geometric mean of 4.4 104 CFU per cell culture
well, whereas cells infected with LC101 showed significantly
fewer intracellular bacteria (geometric mean, 2.4  104 CFU
per well) (Fig. 1A). We determined the binding of bacteria to
cells by fluorescence-activated cell sorter analysis. Both K56-2
and LC101 bound to IB3 cells in very low numbers, with the
wild-type bacteria showing 1.5-fold more binding than the mu-
tant LC101 (data not shown).
In intracellular-replication assays, cells were infected with
bacteria at an MOI of 1.0 and processed as in the invasion
assay but then incubated for a further 20 h before being lysed
and plated for bacterial counts. Cells incubated with K56-2
showed a geometric mean of 1.3  106 CFU per well. In
contrast, cells infected with LC101 showed a geometric mean
of 8.3  104 CFU per well (Fig. 1B). To confirm intracellular
replication, cells infected with either the wild type or mutant
were fixed/permeabilized and immunostained with antibody to
B. cenocepacia and subjected to confocal microscopy. Micro-
colonies of both wild-type and mutant bacteria were clearly
observed inside the cells, indicating intracellular replication
(Fig. 2). However, while large clumps of wild-type bacteria
were observed in the perinuclear area, groups of only three or
four LC101 bacteria were observed, primarily in the perinu-
clear area and sometimes in the cytoplasm. These results in-
dicate that LC101 is significantly attenuated in its capacity to
bind, invade, and replicate in IB3 cells compared to the K56-2
parent.
B. cenocepacia was previously shown to enter and replicate
in U937-derived macrophages (20). We therefore examined
the effect of inactivating the Ptw T4SS on this process. U937
cells were stimulated with PMA to promote their differentia-
tion into macrophages and infected with wild-type K56-2 or
LC101 at an MOI of 1.0. At 4 h postinfection, four times fewer
intracellular LC101 than wild-type K56-2 bacteria were found,
although this difference was not statistically significant (Fig.
3A). For both K56-2 and LC101, negligible numbers of bacte-
ria were recovered after washing (data not shown). At 24 h
postinfection, significantly fewer LC101 bacteria than the
K56-2 parent were found within macrophages (Fig. 3B). Con-
focal microscopy revealed large numbers of intracellular wild-
type bacteria with no degraded bacterial particles within the
cells. In contrast, only two or three LC101 bacteria were ob-
served, with copious degraded bacterial particles within the
cells (Fig. 4). These findings suggest that although the wild-
type strain and the LC101 mutant are internalized by macro-
phages at comparable rates, the intracellular replication and
survival of the wild-type strain are greater than those of the
mutant.
We evaluated the viability of IB3 cells and macrophages
after bacterial infection by using a Live/Dead assay. We found
FIG. 1. Invasion and intracellular replication of K56-2 and LC101
in IB3 airway epithelial cells. IB3 cells were infected with K56-2 or
LC101 at an MOI of 1 (replication) or 10 (invasion) and incubated for
2 h. Extracellular bacteria were killed by treating them with gentamicin
and ceftazidime. The cells were either lysed with Triton X-100 (inva-
sion experiments) or incubated for a further 20 h in the presence of
gentamicin (replication experiments). The cells were washed, lysed
with Triton X-100, and plated to determine the number of live bacte-
ria. (A and B) Invasion and intracellular replication, respectively. The
data represent geometric means (SEM) calculated from three or
four independent experiments, each performed in triplicate. (*, P 
0.05; Student’s t test.)
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that 71.7%  4.5% of IB3 cells infected with K56-2 were
viable, whereas 64.7% 4.0% of IB3 cells infected with LC101
were viable; this difference was not statistically significant. We
further found that 57.6%  12.0% of macrophages infected
with K56-2 were viable, whereas 47.4%  11.1% of macro-
phages infected with LC101 were viable; again, this was not a
statistically significant difference.
We complemented LC101 with the full-length ptwD4 gene,
along with its upstream predicted promoter region, and were
able to detect the wild-type gene by PCR for at least five serial
passages on nonselective medium. We then examined the ca-
pacity of the complemented mutant to invade and replicate in
both cell types. Although complementation with ptwD4 par-
tially restored the capacity of LC101 to invade and replicate in
IB3 cells, we found no complementation of these phenotypes
in macrophages (data not shown). RT-PCR analyses detected
transcripts of all four ORFs immediately downstream of the
targeted ptwD4 gene in K56-2, as well as LC101, suggesting
that the mutation is not polar. We also sought to investigate
the possible roles of other genes in the plasmid-encoded T4SS
using previously constructed mutants that were shown to ab-
rogate water soaking (9). None of these other mutants, how-
ever, was stable under the current experimental conditions.
Intracellular processing of K56-2 and LC101. To investigate
whether the differences we observed in intracellular survival
between the wild-type K56-2 and LC101 involved differences in
intracellular bacterial processing, we colocalized bacteria in
infected IB3 cells and macrophages with markers of the endo-
cytic pathway. We previously demonstrated that following in-
fection of airway epithelial cells, wild-type K56-2 enters early
endosomes but escapes from late endosomes to transiently
FIG. 2. Replication of K56-2 and LC101 inside IB3 cells. IB3 cells were infected with K56-2 (A to C) or LC101 (D to F) at an MOI of 100 and
incubated for 2 h. Extracellular bacteria were killed by treating them with gentamicin and ceftazidime, and the cells were incubated for another
16 h in the presence of gentamicin. The cells were washed with PBS, fixed with cold methanol, and blocked, and bacteria were detected by using
antibody to B. cenocepacia. The cells were imaged by confocal microscopy. (A and D) Differential interference contrast images of panels B and
E, respectively. (C and F) Overlays of panels A and B, and D and F, respectively.
FIG. 3. Invasion and intracellular replication of K56-2 and
LC101 in U937 cells. Monocyte-derived macrophages (U937) were
infected with K56-2 or LC101 at an MOI of 1, and invasion and
replication were determined as described in the legend to Fig. 1. (A
and B) Invasion and intracellular replication, respectively. The data
represent geometric means (SEM) calculated from three or four
independent experiments, each performed in triplicate. (*, P 
0.05; Student’s t test.)
5450 SAJJAN ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
reside in autophagosomes that apparently fail to fuse with
mature lysosomes (30). The bacteria ultimately colocalize with
ER-derived vesicles, where they appear to replicate. Heat-
killed K56-2, in contrast, appeared to be targeted to the clas-
sical endocytic degradative pathway, entering late endosomes
that fused with lysosomes. In the present study, K56-2 and
LC101 were observed in early endosome marker EEA1-posi-
tive vacuoles in both IB3 cells and macrophages 30 min postin-
fection (data not shown). At 2 h postinfection, however, 9.5%
of LC101 bacteria colocalized with the late endosome marker
Rab7 while only 4.3% of wild-type K56-2 did so (Fig. 5),
suggesting that unlike wild-type bacteria, LC101 is deficient in
its ability to escape from late endosomes.
To investigate whether internalized wild-type K56-2 and LC101
enter autophagosomes, we assessed bacterial colocalization with
the lysosomal/endosomal marker LAMP1 and with the ER
marker calnexin, which are characteristic components of autopha-
gosomes. The acid hydrolase cathepsin D was used as a marker
for mature autophagolysosomes (15). Four hours after infection
of IB3 cells, 80% of the intracellular wild type K56-2 bacteria
were observed in calnexin-positive vacuoles. At that time point,
	20% of intracellular K56-2 bacteria colocalized with LAMP1,
indicative of their presence in autophagosomes (24). Fewer than
10% of intracellular K56-2 bacteria colocalized with cathepsin D.
In contrast, only 	50% of LC101 bacteria colocalized with cal-
nexin and fewer than 5% colocalized with LAMP1. Approxi-
mately 30% of LC101 bacteria colocalized with vacuoles positive
for cathepsin D. We also observed that intracellular LC101 bac-
teria were often disintegrated by 4 h postinfection; however, this
was not observed in K56-2-infected cells (data not shown). At
24 h postinfection, 98% of intracellular K56-2 and 38% of LC101
bacteria were found in vacuoles positive for calnexin (Fig. 6A).
However, whereas 28% of LC101 bacteria were in cathepsin
D-positive vacuoles, only 9% of K56-2 bacteria colocalized with
cathepsin D at that time point (Fig. 6B).
We next similarly infected and examined U937 monocyte-
derived macrophages. At 4 h postinfection, we observed that
greater than 90% of intracellular bacteria in both K56-2- and
FIG. 4. Replication of K56-2 and LC101 in macrophages. PMA-treated U937 cells were infected with K56-2 (A to C) or LC101 (D to F) at an
MOI of 100 and incubated for 2 h. Extracellular bacteria were killed by treating them with gentamicin and ceftazidime, and the cells were incubated
for another 16 h in the presence of gentamicin. The cells were washed with PBS, fixed with cold methanol, and blocked, and bacteria were detected
by using antibody to B. cenocepacia. The cells were imaged by confocal microscopy. (A and D) DIC images of panels B and E, respectively. (C
and F) Overlays of panels A and B, and D and E, respectively.
FIG. 5. Colocalization of K56-2 and LC101 with the late endosome
marker Rab7 in infected IB3 cells and macrophages. IB3 cells and
U937-derived macrophages were infected with K56-2 or LC101 at an
MOI of 20 and incubated for 2 h. The infected cells were incubated
with antibodies to Rab7 and B. cenocepacia, and bound antibody was
visualized by confocal microscopy. The proportion of intracellular
K56-2 (open bars) and LC101 (closed bars) colocalizing with Rab7 in
each cell type is shown. The bars represent geometric means and SEM
from counting intracellular bacteria in 10 microscopic fields from three
independent experiments. A total of 692 bacteria in 40 fields were
counted. The differences between K56-2 and LC101 are not statisti-
cally significant.
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LC101-infected macrophages colocalized with calnexin (data
not shown). A majority (90%) of both K56-2 and LC101
bacteria were found to colocalize with calnexin even at 24 h
postinfection (Fig. 6C). In contrast, while 55% of LC101-con-
taining vacuoles were positive for cathepsin D, only 7.7% of
K56-2 bacteria resided in cathepsin D-positive vacuoles (Fig.
6D). At that time point, we also observed bacteria in the
perinuclear area colocalizing with the ER marker calnexin
(Fig. 6E and F).
Acidification of B. cenocepacia-containing vacuoles. We showed
previously that live B. cenocepacia bacteria appear to prevent
acidification of bacterium-containing vacuoles in infected CF air-
way epithelial cells (30). To examine whether the Ptw T4SS con-
tributes to this process, IB3 cells were infected with K56-2 or
LC101 and incubated with LysoTracker Red, which labels acidi-
fied vacuoles. Fewer acidified vacuoles were observed in IB3 cells
infected with K56-2 than in cells infected with LC101 (Fig. 7A and
B). At 2 h postinfection,4% of both K56-2 and LC101 bacteria
were observed in acidified vacuoles (Fig. 7C). By 6 h postinfec-
tion, however, 36% of intracellular LC101 bacteria colocalized
with acidified vacuoles, whereas 13% of K56-2 bacteria were in
acidified vacuoles (Fig. 7C).
FIG. 6. Colocalization of K56-2 and LC101 with autophagosome markers in infected IB3 cells and macrophages. Cells were infected with
K56-2 or LC101 at an MOI of 20 and incubated for 24 h as described in Materials and Methods. The infected cells were incubated with
antibodies to B. cenocepacia and then, in separate experiments, with either calnexin or cathepsin D; bound antibody was visualized by
confocal microscopy. The proportions of intracellular K56-2 and LC101 colocalized with calnexin (A and C) or cathepsin D (B and D) at
24 h in IB3 cells (A and B) and macrophages (C and D) are shown. The bars represent geometric means and SEM from counting intracellular
bacteria in 10 to 12 microscopic fields from three independent experiments. A total of 1,716 bacteria in 42 fields were counted for calnexin
and 2,362 bacteria in 40 fields for cathepsin D. (E and F) Colocalization of K56-2 (E) or LC101 (F) and calnexin (arrows) in macrophages
24 h postinfection showing bacteria in the perinuclear area. (*, P  0.05; Student’s t test; the absence of an asterisk indicates that the
difference is not statistically significant.)
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FIG. 7. Colocalization of K56-2 or LC101 and LysoTracker Red-positive vacuoles in IB3 cells and macrophages. IB3 cells (A and B) and
macrophages (D and E) were infected with FITC-labeled K56-2 (A and D) or LC101 (B and E) at an MOI of 20 and processed as described in
Materials and Methods. Green and red represent bacteria and LysoTracker Red-positive vacuoles, respectively. The arrows indicate bacteria
colocalized with LysoTracker Red-positive vacuoles. The proportions of K56-2 (open bars) or LC101 (closed bars) colocalized with LysoTracker
Red vacuoles in infected IB3 cells (C) or macrophages (F) are shown. The bars represent geometric means and SEM from counting intracellular
bacteria in 10 microscopic fields from three independent experiments. A total of 1,179 bacteria in 80 fields were counted. (*, P  0.05; Student’s
t test.)
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We similarly examined infected U937-derived macrophages
(Fig. 7D and E). At both 30 min and 6 h postinfection, a
greater proportion of LC101 than of the parent K56-2 bacteria
colocalized with acidified vacuoles (Fig. 7F).
DISCUSSION
B. cenocepacia, a species within the B. cepacia complex, is a
bacterial pathogen of considerable concern for persons with CF.
Infection of the respiratory tracts of CF patients by this species is
most often chronic, refractory to antimicrobial therapy, and asso-
ciated with significantly increased rates of morbidity and mortality
(19). Unfortunately, relatively little is known about the patho-
genic mechanisms of B. cenocepacia in CF.
The capacity of B. cenocepacia to survive and replicate
within eukaryotic host cells may contribute to the organism’s
ability to persist and evade host defenses in vivo during chronic
infection. Recently, we and others have shown that the intra-
cellular survival of B. cenocepacia appears to involve modula-
tion of the normal endocytic pathway of macrophages and CF
airway epithelial cells (16, 30). Similar intracellular survival
and replication of other pathogenic bacteria, including L.
pneumophila and Brucella, Chlamydia, and Salmonella species,
often involves bacterial effector proteins secreted by type III
secretion systems or T4SSs (8, 14, 25, 33, 35, 38). The recent
identification of T4SSs in B. cenocepacia, therefore, led us to
investigate whether they similarly play a role in the species’
intracellular survival.
To construct a mutant deficient in the plasmid-encoded
T4SS, we focused on ptwD4, a gene that predicts a protein with
strong homology to coupling proteins of other T4SSs. Inacti-
vation of coupling proteins abrogates the secretion of T4SS
effector proteins in other species (4). We found that although
both wild-type K56-2 and LC101 were capable of entering and
surviving in CF airway epithelial cells and monocyte-derived
macrophages, fewer mutant bacteria were recovered from cells
4 h after infection. By 24 h postinfection, the numbers of T4SS
mutant bacteria found within both epithelial cells and macro-
phages were significantly reduced compared to the wild-type
strain. Although wild-type K56-2 showed 1.5 times more bind-
ing to cells than LC101, the overall level of bacterial binding
was quite low. Furthermore, this observed difference in binding
between K56-2 and LC101 seems quite unlikely to account for
the greater than 10-fold difference between viable K56-2 and
LC101 bacteria recovered from cells after 24 h. We also mea-
sured the viability of IB3 and U937 cells 24 h after infection to
determine whether the observed differences in levels of intra-
cellular bacteria (between K56-2- and LC101-infected cells)
were due to differences in infected-cell viability. We did not
find a significant difference in viability between cells infected
with K56-2 and cells infected with LC101. In a previous study,
Saini et al. (26) found that strains of Burkholderia vietnamiensis
and Burkholderia dolosa survived without replication in murine
macrophages for several days. Our results are consistent with
those of Martin and Mohr (20), who found replication of B.
cenocepacia J2315 (another representative of the ET12 lin-
eage) in U937 monocyte-derived macrophages. Also similar to
our observations, Martin and Mohr (20) found visible disrup-
tion of macrophage (U937) and epithelial cell monolayers 24 h
after infection with B. cenocepacia, suggesting that the species
is cytotoxic to cultured human cells. Our results suggest that
the plasmid- encoded T4SS plays a role in the intracellular
survival of B. cenocepacia in both professional and nonprofes-
sional phagocytes.
We previously reported that internalized B. cenocepacia bac-
teria escape from the normal endocytic pathway and enter
autophagosomes (based on colocalization with monodansyl ca-
daverine) that fail to mature into autophagolysosomes (30). In
the current study, we compared the intracellular processing of
the T4SS mutant and the parent strain to determine if the
plasmid-encoded T4SS plays a role in modulating phagosome
maturation, which could explain the decreased capacity of the
mutant to persist intracellularly. Both wild-type K56-2 and
LC101 appeared to enter the normal endocytic pathway, as
both strains colocalized with the early endosome marker
EEA1, irrespective of the host cell type. Shortly after infection
of either epithelial cells or macrophages, however, more than
twice as many mutant-containing vacuoles colocalized with late
endosomal and lysosomal markers as did vacuoles containing
wild-type bacteria, suggesting that a proportion of internalized
LC101 mutant bacteria were quickly targeted to the classic
endocytic pathway. At 24 h postinfection, approximately two or
three times as many LC101 mutant bacteria were found in
cathepsin D-positive vacuoles as the parent strain in both ep-
ithelial cells and macrophages, and LC101 bacteria were often
observed as degraded particles. The relatively low level of
colocalization of wild-type bacteria and cathepsin D, a marker
of mature autophagolysosomes, suggests that the plasmid-en-
coded T4SS may allow B. cenocepacia to inhibit fusion of
bacterium-containing autophagosomes with lysosomes.
We previously demonstrated that CF epithelial cells treated
with heat-killed B. cenocepacia showed many more bacteria
colocalizing with acidified vacuoles than were observed in cells
infected with live B. cenocepacia bacteria (30). In the current
study, we similarly found more than twice as many acidified
bacterium-containing vacuoles in LC101 mutant-infected epi-
thelial cells and macrophages as in cells infected with the
wild-type strain. Collectively, these results suggest that more
LC101 bacteria are killed via the endocytic pathway soon after
entering host cells. Effector substrates delivered by the T4SS
may be involved in diverting wild-type B. cenocepacia from this
pathway, altering lysosome fusion with autophagosomes and
preventing acidification of bacterium-containing vacuoles.
Our results are consistent with observations of other intra-
cellular pathogens whose T4SSs are capable of altering mem-
brane trafficking. Effectors secreted by the Dot/Icm T4SS of L.
pneumophila alter host membrane trafficking and impede pha-
gosome-lysosome fusion, establishing a vacuole permissive of
bacterial replication (37). In Brucella abortus, a functional
T4SS is necessary to escape the degradative endocytic pathway
and to establish an ER-derived replication vacuole (7).
Inactivation of ptwD4 did not completely abolish the capac-
ity of the mutant to persist intracellularly or to evade phago-
some-lysosome fusion. It is possible that the chromosomally
encoded VirB/VirD T4SS system of B. cenocepacia may com-
pensate for the deficiency of the plasmid-encoded T4SS. It is
also possible that separate classes of effectors are responsible
for evasion of lysosome fusion and for transport of bacterium-
containing phagosomes to the ER (22). Other mechanisms
distinct from the T4SS may act in addition to or instead of
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secreted bacterial substrates to form the intracellular niche
permissive for B. cenocepacia persistence. T4SS-independent
mechanisms that inhibit phagosome-lysosome fusion have
been identified in L. pneumophila (10). Further studies to look
at these alternatives and to identify the T4SS effector proteins
that are required for intracellular persistence of B. cenocepacia
are in progress. Although several candidate proteins contain-
ing a positively charged C-terminal transport signal motif sim-
ilar to that found A. tumefaciens effector proteins (36) have
been identified, none has yet been shown to be involved in the
Ptw T4SS.
In summary, the studies described in this report indicate that
a functional plasmid-encoded T4SS contributes to the ability of
B. cenocepacia to evade endocytic degradation and to survive
and replicate in both airway epithelial cells and monocyte-
derived macrophages. The contribution of the Ptw T4SS to this
potential virulence phenotype provides ample incentive for
further studies, such as identification of the effector protein(s)
and construction of double (Ptw and VirB/VirD) mutants, to
characterize the role of these T4SSs in B. cenocepacia viru-
lence.
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